Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin J Ostrin

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Cell Reports. Medicine|December 17, 2025
Lung adenocarcinoma surfaceome remodeling with EGFR inhibitors uncovers placental alkaline phosphatase as a target for combination therapyYihui Chen, Rongzhang Dou, Monica J Hong, et al.
Vaccines|June 27, 2025
Citrullinated ENO1 Vaccine Enhances PD-1 Blockade in Mice Implanted with Murine Triple-Negative Breast Cancer CellsRicardo A León-Letelier, Alejandro M Sevillano-Mantas, Yihui Chen, et al.
Journal of the National Cancer Institute|April 5, 2017
Role of CPS1 in Cell Growth, Metabolism and Prognosis in LKB1-Inactivated Lung AdenocarcinomaMüge Çeliktas, Ichidai Tanaka, Satyendra Chandra Tripathi, et al.
JCI Insight|April 26, 2022
Targeting IL-1β as an immunopreventive and therapeutic modality for K-ras-mutant lung cancerBo Yuan, Michael J Clowers, Walter V Velasco, et al.
Cancers|May 28, 2025
High <i>KYNU</i> Expression Is Associated with Poor Prognosis, <i>KEAP1</i>/<i>STK11</i> Mutations, and Immunosuppressive Metabolism in Patient-Derived but Not Murine Lung AdenocarcinomasLing Cai, Thomas J Rogers, Reza Mousavi Jafarabad, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2016
Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcomeSatyendra C Tripathi, Haley L Peters, Ayumu Taguchi, et al.
Cancer Research|May 20, 2016
IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras-Mutant Lung CancerMauricio S Caetano, Huiyuan Zhang, Amber M Cumpian, et al.
International Journal of Molecular Sciences|February 24, 2024
Circulating microRNA Panel for Prediction of Recurrence and Survival in Early-Stage Lung AdenocarcinomaMei-Chee Tai, Leonidas E Bantis, Gargy Parhy, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 5, 2025
The LEAP Study: A Multicenter Biospecimen and Imaging Resource for Lung Cancer ScreeningJennifer B Dennison, Sebastien Gendarme, Nicole M Kettner, et al.
Carcinogenesis|July 1, 2020
Interplay between estrogen and Stat3/NF-κB-driven immunomodulation in lung cancerShanshan Deng, Marco Ramos-Castaneda, Walter V Velasco, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Cell Reports. Medicine|December 17, 2025
Lung adenocarcinoma surfaceome remodeling with EGFR inhibitors uncovers placental alkaline phosphatase as a target for combination therapyYihui Chen, Rongzhang Dou, Monica J Hong, et al.
Vaccines|June 27, 2025
Citrullinated ENO1 Vaccine Enhances PD-1 Blockade in Mice Implanted with Murine Triple-Negative Breast Cancer CellsRicardo A León-Letelier, Alejandro M Sevillano-Mantas, Yihui Chen, et al.
Journal of the National Cancer Institute|April 5, 2017
Role of CPS1 in Cell Growth, Metabolism and Prognosis in LKB1-Inactivated Lung AdenocarcinomaMüge Çeliktas, Ichidai Tanaka, Satyendra Chandra Tripathi, et al.
JCI Insight|April 26, 2022
Targeting IL-1β as an immunopreventive and therapeutic modality for K-ras-mutant lung cancerBo Yuan, Michael J Clowers, Walter V Velasco, et al.
Cancers|May 28, 2025
High <i>KYNU</i> Expression Is Associated with Poor Prognosis, <i>KEAP1</i>/<i>STK11</i> Mutations, and Immunosuppressive Metabolism in Patient-Derived but Not Murine Lung AdenocarcinomasLing Cai, Thomas J Rogers, Reza Mousavi Jafarabad, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2016
Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcomeSatyendra C Tripathi, Haley L Peters, Ayumu Taguchi, et al.
Cancer Research|May 20, 2016
IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras-Mutant Lung CancerMauricio S Caetano, Huiyuan Zhang, Amber M Cumpian, et al.
International Journal of Molecular Sciences|February 24, 2024
Circulating microRNA Panel for Prediction of Recurrence and Survival in Early-Stage Lung AdenocarcinomaMei-Chee Tai, Leonidas E Bantis, Gargy Parhy, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 5, 2025
The LEAP Study: A Multicenter Biospecimen and Imaging Resource for Lung Cancer ScreeningJennifer B Dennison, Sebastien Gendarme, Nicole M Kettner, et al.
Carcinogenesis|July 1, 2020
Interplay between estrogen and Stat3/NF-κB-driven immunomodulation in lung cancerShanshan Deng, Marco Ramos-Castaneda, Walter V Velasco, et al.
Pageof 6